Журнал лейкемии
Открытый доступ
ISSN: 2329-6917
ISSN: 2329-6917
Cesar Alfredo Pena Ramos
Plasma Cell Leukemia (PCL) is a plasma cell dyscrasia, for example an infection including the harmful degeneration of a subtype of white platelets called plasma cells. It is the terminal stage and most forceful type of these dyscrasias, establishing 2%to 4% of all instances of plasma cell malignancies. PCL might present as essential plasma cell leukemia, for example in patients without earlier history of a plasma cell dyscrasia or as auxiliary plasma cell dyscrasia, for example in patients recently determined to have a background marked by its archetype dyscrasia, different myeloma [1]. The two types of PCL seem, by all accounts, to be unquestionably somewhat unmistakable from one another. In all cases, notwithstanding, PCL is a very genuine, dangerous, and remedially testing illness [2].